Search Videos and More
Showing 1 - 12 of 12 results
News
Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row
U.S. News & World Report has again recognized Dana-Farber/Boston Children's Cancer and Blood Disorders Center as the #2 pediatric cancer program in the nation in its 2024-25 Best Children's Hospitals report.
News
U.S. News & World Report names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2024-2025
For the 24th consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report.
News
Jose Cancelas Named Director of the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Jose Cancelas, MD, PhD, recently joined Dana-Farber Cancer Institute as the director of the Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF).
News
Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
Gordon J. Freeman, PhD, of Dana-Farber Cancer Institute, will receive the 2024 AACR-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology from the American Association for Cancer Research (AACR).
News
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nations’ Best for 2023-2024
For the 23rd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report.
News
Dana-Farber/Boston Children's Again Ranked Among the Best Pediatric Cancer Programs in the Nation
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the #2 pediatric program in the nation in its 2023-24 Best Children's Hospitals report.
News
More Than 120 Dana-Farber Affiliated Faculty Named as 2023 Top Doctors in Boston Magazine
Boston magazine has named more than 120 physicians affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide.
News
Dana-Farber’s Kornelia Polyak Elected to the National Academy of Medicine
Kornelia Polyak, M.D., Ph.D., professor of medicine, medical oncology, Dana-Farber Cancer Institute has been elected to the prestigious National Academy of Medicine.
News
Kornelia Polyak Wins Prestigious American Cancer Society Award
Kornelia Polyak, MD, PhD, a breast cancer researcher at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School is the recipient of the American Cancer Society’s prestigious Research Professor Award.
News
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023
For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.
News
Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center #1 in the nation in its 2022-23 Best Children's Hospitals report. Dana-Farber/Boston Children's has been recognized as one of the top three pediatric cancer centers in the country each year since the ranking's inception, earning more #1 rankings than any other program.
News
Newsweek Names Dana-Farber #3 in the World for Cancer
Dana-Farber Cancer Institute has been named one of the world’s very best cancer hospitals by Newsweek in its new World’s Best Specialized Hospitals 2022 rankings.